PACIULLO, FRANCESCO
 Distribuzione geografica
Continente #
EU - Europa 1.700
AS - Asia 1.541
NA - Nord America 918
SA - Sud America 355
AF - Africa 52
OC - Oceania 14
Totale 4.580
Nazione #
RU - Federazione Russa 1.021
US - Stati Uniti d'America 849
SG - Singapore 586
CN - Cina 415
BR - Brasile 294
IT - Italia 249
HK - Hong Kong 212
VN - Vietnam 137
FR - Francia 94
DE - Germania 92
GB - Regno Unito 58
IN - India 57
CA - Canada 40
NL - Olanda 40
AT - Austria 31
AR - Argentina 23
IE - Irlanda 21
BD - Bangladesh 19
PL - Polonia 18
IQ - Iraq 17
MX - Messico 17
ZA - Sudafrica 16
AU - Australia 14
ES - Italia 14
ID - Indonesia 13
SE - Svezia 12
TR - Turchia 12
FI - Finlandia 10
LT - Lituania 10
PE - Perù 9
PH - Filippine 8
JP - Giappone 7
CH - Svizzera 6
CL - Cile 6
CO - Colombia 6
KE - Kenya 6
SA - Arabia Saudita 6
UZ - Uzbekistan 6
VE - Venezuela 6
DO - Repubblica Dominicana 5
EC - Ecuador 5
IL - Israele 5
PK - Pakistan 5
RO - Romania 5
BE - Belgio 4
BW - Botswana 4
GR - Grecia 4
LA - Repubblica Popolare Democratica del Laos 4
MA - Marocco 4
MY - Malesia 4
NG - Nigeria 4
PY - Paraguay 4
UA - Ucraina 4
BG - Bulgaria 3
CR - Costa Rica 3
ET - Etiopia 3
JO - Giordania 3
KZ - Kazakistan 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
BB - Barbados 2
EG - Egitto 2
LK - Sri Lanka 2
SC - Seychelles 2
SN - Senegal 2
TZ - Tanzania 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CD - Congo 1
CG - Congo 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
KR - Corea 1
LB - Libano 1
LI - Liechtenstein 1
MD - Moldavia 1
MN - Mongolia 1
MZ - Mozambico 1
NP - Nepal 1
PS - Palestinian Territory 1
TH - Thailandia 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
YE - Yemen 1
Totale 4.580
Città #
Singapore 353
Hong Kong 211
Moscow 185
Ashburn 163
Dallas 114
Hefei 77
Lauterbourg 70
Shanghai 62
Milan 56
San Jose 54
New York 50
Ho Chi Minh City 46
Los Angeles 35
Hanoi 33
São Paulo 32
Orem 30
Boardman 29
Munich 26
Nuremberg 26
Beijing 21
Dublin 19
Santa Clara 18
Montreal 16
Denver 15
Frankfurt am Main 15
Vienna 15
London 14
Rome 14
Warsaw 14
Amsterdam 13
Brooklyn 13
Manchester 12
Boston 11
Chennai 11
Johannesburg 11
Bengaluru 10
Council Bluffs 10
Falkenstein 10
Rio de Janeiro 10
Stockholm 10
Atlanta 9
Chicago 9
Guangzhou 9
Sydney 9
Da Nang 8
Mumbai 8
Phoenix 8
Belo Horizonte 7
Haiphong 7
Helsinki 7
Poplar 7
Tokyo 7
Turin 7
Baghdad 6
Bologna 6
Catania 6
Lima 6
Mexico City 6
San Francisco 6
Tashkent 6
Toronto 6
Ankara 5
Calgary 5
Houston 5
Miami 5
St Louis 5
Tianjin 5
Zurich 5
Curitiba 4
Florence 4
Fortaleza 4
Gaborone 4
Genoa 4
Guarulhos 4
Hangzhou 4
Hayes 4
Jundiaí 4
Nairobi 4
Natal 4
Santo André 4
Santo Domingo 4
Seattle 4
Shenzhen 4
Vientiane 4
Addis Ababa 3
Amman 3
Asunción 3
Bari 3
Birmingham 3
Biên Hòa 3
Bogotá 3
Brussels 3
Bucharest 3
Charlotte 3
City of London 3
Cleveland 3
Concord 3
Dhaka 3
Duque de Caxias 3
Figino 3
Totale 2.231
Nome #
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 123
Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study 120
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 107
Appropriateness of antiplatelet therapy for primary and secondary cardio‐ and cerebrovascular prevention in acutely hospitalized older people 104
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 102
Antipsychotic prescription and mortality in hospitalized older persons 95
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 94
Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry 86
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 85
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 83
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 83
Association of Neutrophil Activation, More Than Platelet Activation, with Thrombotic Complications in Coronavirus Disease 2019 83
Deficiency of natural anticoagulants: how should we manage cardiovascular prevention? 82
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 82
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 77
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 76
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 74
Measurement of arterial stiffness in antiphospholipid syndrome: a step forward in cardiovascular risk stratification? 74
Effect of statin intake on FVIII levels and bleeding outcomes in hypercholesterolemic patients with hemophilia A 73
Gender-differences in disease distribution and outcome in hospitalized elderly : Data from the REPOSI study 72
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) 72
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 71
Drug-drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 67
Prognostic value of degree and types of anaemia on clinical outcomes for hospitalised older patients 67
Prevalence and Risk Factors Associated with Use of QT-Prolonging Drugs in Hospitalized Older People 66
Antithrombotic treatment of asymptomatic carotid atherosclerosis: a medical dilemma 66
Baseline and post-surgery endothelial progenitor cell levels in patients with early-stage non-small-cell lung carcinoma: impact on cancer recurrence and survival 66
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry 66
Effect of statins on measures of coagulation: potential role of low-density lipoprotein receptors 65
Sex-Differences in the Pattern of Comorbidities, Functional Independence, and Mortality in Elderly Inpatients: Evidence from the RePoSI Register 65
Risk factors for three-month mortality after discharge in a cohort of non-oncologic hospitalized elderly patients: Results from the REPOSI study 65
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 65
Heart failure and chronic kidney disease in a registry of internal medicine wards 65
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 65
Pattern of in‐hospital changes in drug use in the older people from 2010 to 2016 64
Defining Aging Phenotypes and Related Outcomes: Clues to Recognize Frailty in Hospitalized Older Patients 64
The stigma of low opioid prescription in the hospitalized multimorbid elderly in Italy 64
Role of Increased Lipoprotein (a) in Retinal Vein Occlusion: A Systematic Review and Meta-analysis 63
Underdiagnosis and undertreatment of osteoporotic patients admitted in internal medicine wards in Italy between 2010 and 2016 (the REPOSI Register) 61
Antibiotic use and associated factors in a large sample of hospitalised older people 61
Antiplatelet Therapy in Low-Platelet-Count Patients After Percutaneous Coronary Intervention for Acute Coronary Syndromes 60
Prognostic relevance of glomerular filtration rate estimation obtained through different equations in hospitalized elderly patients 56
Joint use of cardio-embolic and bleeding risk scores in elderly patients with atrial fibrillation 55
Inappropriate prescription of allopurinol and febuxostat and risk of adverse events in the elderly: results from the REPOSI registry 54
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 54
Therapeutic Duplicates in a Cohort of Hospitalized Elderly Patients: Results from the REPOSI Study 52
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis 52
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 52
The response of the emergency-urgency system in Umbria during the COVID-19 pandemic 52
Long noncoding RNAs: new insights into non-small cell lung cancer biology, diagnosis and therapy 52
Rivaroxaban Plasma Levels and Levetiracetam RESPONSE 50
Use of non-steroidal anti-inflammatory drugs and analgesics in a cohort of hospitalized elderly patients: Results from the REPOSI study 49
Role of endothelial dysfunction in the thrombotic complications of COVID-19 patients 49
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity 48
PCSK9 at the crossroad of cholesterol metabolism and immune function during infections 47
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 47
Vitamin B12 levels in patients with retinal vein occlusion and their relation with clinical outcome: a retrospective study 45
Living alone as an independent predictor of prolonged length of hospital stay and non-home discharge in older patients 45
Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey 45
High - but not standard-dose atorvastatin prevents the increase of plasma matrix metalloproteinase-2 triggered by acute coronary syndromes 44
Rivaroxaban Plasma Levels and Levetiracetam: A Case Report 44
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 43
Long-term treatment with thalidomide for severe recurrent hemorrhage from intestinal angiodysplasia in Glanzmann Thrombasthenia 42
On-treatment C-reactive protein and HDL cholesterol levels in patients at intermediate cardiovascular risk: Impact on carotid intima-media thickness 42
Strategies for prevention of SARS-CoV-2 infection in a rural Emergency Department 39
Olanzapine-associated hypothermia: a case report of a rare event 38
Increased plasma PCSK-9 is associated with restenosis in patients undergoing carotid endarterectomy 38
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia 38
Persistence on apixaban in atrial fibrillation patients: a retrospective multicentre study 36
Reduced survival in patients with early-stage non-small-cell lung cancer is associated with high pleural endothelial progenitor cell levels 35
Eltrombopag to allow chemotherapy in a patient withMYH9-related inherited thrombocytopenia and pancreatic cancer 35
PCSK9 in Haemostasis and Thrombosis: Possible Pleiotropic Effects of PCSK9 Inhibitors in Cardiovascular Prevention 35
Epidemiology of emergency calls for time-dependent acute illnesses during COVID-19 outbreak in Umbria region (Italy) 35
Pleiotropic effects of PCSK9-inhibition on hemostasis: Anti-PCSK9 reduce FVIII levels by enhancing LRP1 expression 31
Inappropriate prescription of benzodiazepines in acutely hospitalized older patients 31
Lipoprotein(a) and inflammation: A dangerous duet leading to endothelial loss of integrity 28
Totale 4.681
Categoria #
all - tutte 16.235
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202428 0 0 0 0 0 0 0 0 0 0 19 9
2024/20251.028 43 2 6 80 52 110 252 70 99 107 89 118
2025/20263.625 299 346 193 433 292 229 329 307 1.041 156 0 0
Totale 4.681